nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A4—Temozolomide—malignant glioma	0.257	1	CbGbCtD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—POR—malignant glioma	0.0206	0.0647	CbGpPWpGaD
Eplerenone—NR3C2—Preimplantation Embryo—MYBL1—malignant glioma	0.0169	0.0531	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—BDKRB2—malignant glioma	0.0144	0.0451	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—KNG1—malignant glioma	0.0131	0.041	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—BDKRB2—malignant glioma	0.0117	0.0369	CbGpPWpGaD
Eplerenone—Influenza-like symptoms—Temozolomide—malignant glioma	0.0111	0.027	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.0107	0.0261	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—KNG1—malignant glioma	0.0107	0.0335	CbGpPWpGaD
Eplerenone—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00966	0.0234	CcSEcCtD
Eplerenone—Endocrine disorder—Temozolomide—malignant glioma	0.00959	0.0233	CcSEcCtD
Eplerenone—Breast pain—Temozolomide—malignant glioma	0.00911	0.0221	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00874	0.0212	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—POR—malignant glioma	0.00873	0.0274	CbGpPWpGaD
Eplerenone—Musculoskeletal pain—Temozolomide—malignant glioma	0.00804	0.0195	CcSEcCtD
Eplerenone—Influenza like illness—Temozolomide—malignant glioma	0.00772	0.0187	CcSEcCtD
Eplerenone—CYP3A7—Xenobiotics—CYP2B6—malignant glioma	0.00741	0.0233	CbGpPWpGaD
Eplerenone—Gynaecomastia—Carmustine—malignant glioma	0.00736	0.0179	CcSEcCtD
Eplerenone—NR3C2—Preimplantation Embryo—SOX2—malignant glioma	0.00735	0.0231	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00726	0.0228	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00716	0.0225	CbGpPWpGaD
Eplerenone—Diabetes mellitus—Carmustine—malignant glioma	0.00686	0.0167	CcSEcCtD
Eplerenone—CYP3A7—Xenobiotics—CYP2C18—malignant glioma	0.00643	0.0202	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—POR—malignant glioma	0.00631	0.0198	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00629	0.0198	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00621	0.0195	CbGpPWpGaD
Eplerenone—Hyponatraemia—Carmustine—malignant glioma	0.00599	0.0145	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00588	0.0185	CbGpPWpGaD
Eplerenone—Hypokalaemia—Carmustine—malignant glioma	0.00543	0.0132	CcSEcCtD
Eplerenone—Dehydration—Temozolomide—malignant glioma	0.00537	0.013	CcSEcCtD
Eplerenone—CYP3A5—Xenobiotics—CYP2B6—malignant glioma	0.00536	0.0168	CbGpPWpGaD
Eplerenone—Hypokalaemia—Temozolomide—malignant glioma	0.00525	0.0127	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00519	0.0126	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.0051	0.016	CbGpPWpGaD
Eplerenone—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00509	0.0124	CcSEcCtD
Eplerenone—Bronchitis—Temozolomide—malignant glioma	0.0048	0.0116	CcSEcCtD
Eplerenone—Hyperglycaemia—Carmustine—malignant glioma	0.00465	0.0113	CcSEcCtD
Eplerenone—CYP3A5—Xenobiotics—CYP2C18—malignant glioma	0.00465	0.0146	CbGpPWpGaD
Eplerenone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00463	0.0112	CcSEcCtD
Eplerenone—Drospirenone—BCHE—malignant glioma	0.00463	0.374	CrCbGaD
Eplerenone—Pneumonia—Carmustine—malignant glioma	0.00463	0.0112	CcSEcCtD
Eplerenone—Depression—Carmustine—malignant glioma	0.00459	0.0111	CcSEcCtD
Eplerenone—Renal failure—Carmustine—malignant glioma	0.00452	0.011	CcSEcCtD
Eplerenone—Neuropathy peripheral—Carmustine—malignant glioma	0.00451	0.0109	CcSEcCtD
Eplerenone—Hyperglycaemia—Temozolomide—malignant glioma	0.0045	0.0109	CcSEcCtD
Eplerenone—Urinary tract infection—Carmustine—malignant glioma	0.00447	0.0109	CcSEcCtD
Eplerenone—Pneumonia—Temozolomide—malignant glioma	0.00447	0.0109	CcSEcCtD
Eplerenone—Infestation—Temozolomide—malignant glioma	0.00445	0.0108	CcSEcCtD
Eplerenone—Infestation NOS—Temozolomide—malignant glioma	0.00445	0.0108	CcSEcCtD
Eplerenone—Depression—Temozolomide—malignant glioma	0.00443	0.0108	CcSEcCtD
Eplerenone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00436	0.0106	CcSEcCtD
Eplerenone—CYP3A5—Irinotecan Pathway—BCHE—malignant glioma	0.00435	0.0137	CbGpPWpGaD
Eplerenone—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00434	0.0136	CbGpPWpGaD
Eplerenone—Urinary tract infection—Temozolomide—malignant glioma	0.00432	0.0105	CcSEcCtD
Eplerenone—Hepatobiliary disease—Temozolomide—malignant glioma	0.0042	0.0102	CcSEcCtD
Eplerenone—Hypoaesthesia—Carmustine—malignant glioma	0.00411	0.00997	CcSEcCtD
Eplerenone—Oedema peripheral—Carmustine—malignant glioma	0.00407	0.00988	CcSEcCtD
Eplerenone—Connective tissue disorder—Carmustine—malignant glioma	0.00406	0.00985	CcSEcCtD
Eplerenone—Hypoaesthesia—Temozolomide—malignant glioma	0.00397	0.00964	CcSEcCtD
Eplerenone—Pharyngitis—Temozolomide—malignant glioma	0.00396	0.00961	CcSEcCtD
Eplerenone—Urinary tract disorder—Temozolomide—malignant glioma	0.00394	0.00957	CcSEcCtD
Eplerenone—Oedema peripheral—Temozolomide—malignant glioma	0.00393	0.00954	CcSEcCtD
Eplerenone—Connective tissue disorder—Temozolomide—malignant glioma	0.00392	0.00952	CcSEcCtD
Eplerenone—Urethral disorder—Temozolomide—malignant glioma	0.00391	0.0095	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00387	0.0122	CbGpPWpGaD
Eplerenone—Flushing—Carmustine—malignant glioma	0.00383	0.0093	CcSEcCtD
Eplerenone—Tinnitus—Temozolomide—malignant glioma	0.00372	0.00903	CcSEcCtD
Eplerenone—Cardiac disorder—Temozolomide—malignant glioma	0.0037	0.00899	CcSEcCtD
Eplerenone—Flushing—Temozolomide—malignant glioma	0.0037	0.00899	CcSEcCtD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00368	0.0116	CbGpPWpGaD
Eplerenone—Angiopathy—Temozolomide—malignant glioma	0.00362	0.00879	CcSEcCtD
Eplerenone—Mental disorder—Carmustine—malignant glioma	0.00362	0.00878	CcSEcCtD
Eplerenone—Mediastinal disorder—Temozolomide—malignant glioma	0.0036	0.00873	CcSEcCtD
Eplerenone—Malnutrition—Carmustine—malignant glioma	0.0036	0.00873	CcSEcCtD
Eplerenone—Methyltestosterone—CYP2B6—malignant glioma	0.00356	0.287	CrCbGaD
Eplerenone—Mental disorder—Temozolomide—malignant glioma	0.0035	0.00849	CcSEcCtD
Eplerenone—Back pain—Carmustine—malignant glioma	0.00348	0.00844	CcSEcCtD
Eplerenone—Malnutrition—Temozolomide—malignant glioma	0.00347	0.00843	CcSEcCtD
Eplerenone—Back pain—Temozolomide—malignant glioma	0.00336	0.00816	CcSEcCtD
Eplerenone—Anaemia—Carmustine—malignant glioma	0.00332	0.00807	CcSEcCtD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00324	0.0102	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Temozolomide—malignant glioma	0.00322	0.00782	CcSEcCtD
Eplerenone—Anaemia—Temozolomide—malignant glioma	0.00321	0.00779	CcSEcCtD
Eplerenone—Angioedema—Temozolomide—malignant glioma	0.00317	0.00771	CcSEcCtD
Eplerenone—Malaise—Temozolomide—malignant glioma	0.00313	0.0076	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP2B6—malignant glioma	0.00313	0.00982	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP2B6—malignant glioma	0.00308	0.00969	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00308	0.00967	CbGpPWpGaD
Eplerenone—Chest pain—Carmustine—malignant glioma	0.00306	0.00743	CcSEcCtD
Eplerenone—Myalgia—Carmustine—malignant glioma	0.00306	0.00743	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00304	0.00955	CbGpPWpGaD
Eplerenone—Cough—Temozolomide—malignant glioma	0.00303	0.00736	CcSEcCtD
Eplerenone—Myalgia—Temozolomide—malignant glioma	0.00296	0.00718	CcSEcCtD
Eplerenone—Arthralgia—Temozolomide—malignant glioma	0.00296	0.00718	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00294	0.00713	CcSEcCtD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00293	0.00922	CbGpPWpGaD
Eplerenone—Discomfort—Temozolomide—malignant glioma	0.00292	0.00709	CcSEcCtD
Eplerenone—Infection—Carmustine—malignant glioma	0.00291	0.00708	CcSEcCtD
Eplerenone—Infection—Temozolomide—malignant glioma	0.00282	0.00684	CcSEcCtD
Eplerenone—Nervous system disorder—Temozolomide—malignant glioma	0.00278	0.00675	CcSEcCtD
Eplerenone—Skin disorder—Temozolomide—malignant glioma	0.00275	0.00669	CcSEcCtD
Eplerenone—Hypotension—Carmustine—malignant glioma	0.00274	0.00665	CcSEcCtD
Eplerenone—Hyperhidrosis—Temozolomide—malignant glioma	0.00274	0.00665	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP2C18—malignant glioma	0.00271	0.00852	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00267	0.00649	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP2C18—malignant glioma	0.00267	0.0084	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00267	0.00839	CbGpPWpGaD
Eplerenone—Insomnia—Carmustine—malignant glioma	0.00265	0.00644	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00263	0.00828	CbGpPWpGaD
Eplerenone—Dyspnoea—Carmustine—malignant glioma	0.00262	0.00635	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00258	0.00627	CcSEcCtD
Eplerenone—Insomnia—Temozolomide—malignant glioma	0.00256	0.00622	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Carmustine—malignant glioma	0.00253	0.00615	CcSEcCtD
Eplerenone—Dyspnoea—Temozolomide—malignant glioma	0.00253	0.00614	CcSEcCtD
Eplerenone—Constipation—Carmustine—malignant glioma	0.00251	0.00609	CcSEcCtD
Eplerenone—Pain—Carmustine—malignant glioma	0.00251	0.00609	CcSEcCtD
Eplerenone—Dyspepsia—Temozolomide—malignant glioma	0.0025	0.00606	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.0025	0.00784	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00249	0.00783	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00245	0.00594	CcSEcCtD
Eplerenone—Fatigue—Temozolomide—malignant glioma	0.00244	0.00593	CcSEcCtD
Eplerenone—Constipation—Temozolomide—malignant glioma	0.00242	0.00589	CcSEcCtD
Eplerenone—Pain—Temozolomide—malignant glioma	0.00242	0.00589	CcSEcCtD
Eplerenone—Feeling abnormal—Carmustine—malignant glioma	0.00242	0.00587	CcSEcCtD
Eplerenone—Gastrointestinal pain—Carmustine—malignant glioma	0.0024	0.00582	CcSEcCtD
Eplerenone—CYP3A5—Irinotecan Pathway—APC—malignant glioma	0.00236	0.00743	CbGpPWpGaD
Eplerenone—Feeling abnormal—Temozolomide—malignant glioma	0.00234	0.00567	CcSEcCtD
Eplerenone—Body temperature increased—Carmustine—malignant glioma	0.00232	0.00563	CcSEcCtD
Eplerenone—Abdominal pain—Carmustine—malignant glioma	0.00232	0.00563	CcSEcCtD
Eplerenone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00232	0.00563	CcSEcCtD
Eplerenone—Abdominal pain—Temozolomide—malignant glioma	0.00224	0.00544	CcSEcCtD
Eplerenone—Body temperature increased—Temozolomide—malignant glioma	0.00224	0.00544	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00223	0.00699	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0022	0.0069	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTT1—malignant glioma	0.00219	0.00689	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00216	0.0068	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00216	0.00679	CbGpPWpGaD
Eplerenone—Drospirenone—PTGS2—malignant glioma	0.00213	0.172	CrCbGaD
Eplerenone—Asthenia—Carmustine—malignant glioma	0.00211	0.00511	CcSEcCtD
Eplerenone—Testosterone—CYP2B6—malignant glioma	0.00207	0.167	CrCbGaD
Eplerenone—CYP11B2—Biological oxidations—PTGS1—malignant glioma	0.00205	0.00645	CbGpPWpGaD
Eplerenone—Asthenia—Temozolomide—malignant glioma	0.00203	0.00494	CcSEcCtD
Eplerenone—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00202	0.00636	CbGpPWpGaD
Eplerenone—Diarrhoea—Carmustine—malignant glioma	0.00201	0.00487	CcSEcCtD
Eplerenone—Pruritus—Temozolomide—malignant glioma	0.00201	0.00487	CcSEcCtD
Eplerenone—Dizziness—Carmustine—malignant glioma	0.00194	0.00471	CcSEcCtD
Eplerenone—Diarrhoea—Temozolomide—malignant glioma	0.00194	0.00471	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00193	0.00606	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0019	0.00598	CbGpPWpGaD
Eplerenone—Dizziness—Temozolomide—malignant glioma	0.00188	0.00455	CcSEcCtD
Eplerenone—Vomiting—Carmustine—malignant glioma	0.00187	0.00453	CcSEcCtD
Eplerenone—Rash—Carmustine—malignant glioma	0.00185	0.00449	CcSEcCtD
Eplerenone—Dermatitis—Carmustine—malignant glioma	0.00185	0.00449	CcSEcCtD
Eplerenone—Headache—Carmustine—malignant glioma	0.00184	0.00446	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.0018	0.00567	CbGpPWpGaD
Eplerenone—Vomiting—Temozolomide—malignant glioma	0.0018	0.00438	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.0018	0.00564	CbGpPWpGaD
Eplerenone—Rash—Temozolomide—malignant glioma	0.00179	0.00434	CcSEcCtD
Eplerenone—Dermatitis—Temozolomide—malignant glioma	0.00179	0.00434	CcSEcCtD
Eplerenone—Headache—Temozolomide—malignant glioma	0.00178	0.00431	CcSEcCtD
Eplerenone—Nausea—Carmustine—malignant glioma	0.00174	0.00423	CcSEcCtD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00171	0.00537	CbGpPWpGaD
Eplerenone—Nausea—Temozolomide—malignant glioma	0.00168	0.00409	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00164	0.00515	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00163	0.00512	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00156	0.00491	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—RTEL1—malignant glioma	0.00154	0.00483	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTP1—malignant glioma	0.00152	0.00477	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTP1—malignant glioma	0.0015	0.00471	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP2B6—malignant glioma	0.00133	0.00417	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP2B6—malignant glioma	0.00131	0.00411	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00119	0.00372	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP2C18—malignant glioma	0.00115	0.00361	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP2C18—malignant glioma	0.00113	0.00356	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00111	0.00349	CbGpPWpGaD
Eplerenone—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.0011	0.00345	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0011	0.00345	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00107	0.00335	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00106	0.00334	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00103	0.00325	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00102	0.00321	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP2B6—malignant glioma	0.000958	0.00301	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000957	0.00301	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP2B6—malignant glioma	0.000945	0.00297	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTT1—malignant glioma	0.000929	0.00292	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000897	0.00282	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000885	0.00278	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—COX8A—malignant glioma	0.000882	0.00277	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—PTGS1—malignant glioma	0.000871	0.00274	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000839	0.00264	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.000831	0.00261	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000822	0.00258	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.000819	0.00257	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000789	0.00248	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—NCOR1—malignant glioma	0.00078	0.00245	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ASMT—malignant glioma	0.00075	0.00236	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000733	0.0023	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—DNMT3B—malignant glioma	0.000729	0.00229	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000727	0.00228	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—HIST1H3B—malignant glioma	0.000708	0.00223	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—BCAN—malignant glioma	0.000705	0.00222	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000672	0.00211	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RTEL1—malignant glioma	0.000651	0.00205	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.000644	0.00202	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.000635	0.002	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.00063	0.00198	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000605	0.0019	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000592	0.00186	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—IDH2—malignant glioma	0.000569	0.00179	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARG—malignant glioma	0.000559	0.00176	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000551	0.00173	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—H3F3A—malignant glioma	0.000547	0.00172	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000536	0.00168	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP2B6—malignant glioma	0.000535	0.00168	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000522	0.00164	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH3—malignant glioma	0.000514	0.00161	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—IDH1—malignant glioma	0.000489	0.00154	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SPHK1—malignant glioma	0.000473	0.00149	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000471	0.00148	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000466	0.00146	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP2C18—malignant glioma	0.000463	0.00146	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH2—malignant glioma	0.000461	0.00145	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000459	0.00144	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000445	0.0014	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000439	0.00138	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000437	0.00137	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000398	0.00125	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—CDKN2B—malignant glioma	0.000396	0.00124	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000386	0.00121	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000384	0.00121	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000381	0.0012	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NCOR1—malignant glioma	0.000376	0.00118	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTT1—malignant glioma	0.000375	0.00118	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—COX8A—malignant glioma	0.000374	0.00118	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS1—malignant glioma	0.000351	0.0011	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00035	0.0011	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000334	0.00105	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—BCHE—malignant glioma	0.000327	0.00103	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC5A5—malignant glioma	0.000323	0.00101	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—malignant glioma	0.000319	0.001	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ASMT—malignant glioma	0.000318	0.001	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000312	0.000982	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000305	0.000959	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000302	0.00095	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—BCAN—malignant glioma	0.000299	0.00094	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000293	0.00092	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH1—malignant glioma	0.000285	0.000896	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—COX8A—malignant glioma	0.00027	0.00085	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARG—malignant glioma	0.000269	0.000846	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000264	0.000828	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—malignant glioma	0.00026	0.000816	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CAT—malignant glioma	0.000253	0.000794	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—IDH2—malignant glioma	0.000241	0.000758	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NCOR1—malignant glioma	0.000239	0.00075	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ASMT—malignant glioma	0.00023	0.000723	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000227	0.000712	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000219	0.000688	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000217	0.00068	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—BCAN—malignant glioma	0.000216	0.000679	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000214	0.000671	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—IDH1—malignant glioma	0.000207	0.000652	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000201	0.00063	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000197	0.000618	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CAV1—malignant glioma	0.000195	0.000612	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000186	0.000584	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CG—malignant glioma	0.000177	0.000557	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—IDH2—malignant glioma	0.000174	0.000548	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARG—malignant glioma	0.000171	0.000538	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000164	0.000515	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000159	0.0005	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CD—malignant glioma	0.000156	0.00049	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—malignant glioma	0.000153	0.000482	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—IDH1—malignant glioma	0.00015	0.000471	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000149	0.000468	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000145	0.000456	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000142	0.000446	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—BCHE—malignant glioma	0.000138	0.000435	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000137	0.00043	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CB—malignant glioma	0.000136	0.000427	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—malignant glioma	0.000135	0.000423	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—COX8A—malignant glioma	0.000126	0.000395	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—malignant glioma	0.000117	0.000369	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000115	0.000361	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—malignant glioma	0.00011	0.000346	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000108	0.000338	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CAT—malignant glioma	0.000107	0.000337	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ASMT—malignant glioma	0.000107	0.000336	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—malignant glioma	0.000106	0.000334	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000101	0.000318	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—BCAN—malignant glioma	0.000101	0.000316	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—BCHE—malignant glioma	0.0001	0.000315	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC5A5—malignant glioma	9.89e-05	0.000311	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—malignant glioma	8.28e-05	0.00026	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CAV1—malignant glioma	8.25e-05	0.000259	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—IDH2—malignant glioma	8.1e-05	0.000255	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—malignant glioma	7.96e-05	0.00025	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CAT—malignant glioma	7.75e-05	0.000244	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.62e-05	0.000239	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CG—malignant glioma	7.52e-05	0.000236	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOR1—malignant glioma	7.32e-05	0.00023	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARG—malignant glioma	7.26e-05	0.000228	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—IDH1—malignant glioma	6.97e-05	0.000219	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—malignant glioma	6.76e-05	0.000213	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SPHK1—malignant glioma	6.74e-05	0.000212	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CD—malignant glioma	6.61e-05	0.000208	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.6e-05	0.000208	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CAV1—malignant glioma	5.97e-05	0.000187	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CB—malignant glioma	5.76e-05	0.000181	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—malignant glioma	5.71e-05	0.000179	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CG—malignant glioma	5.43e-05	0.000171	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—malignant glioma	5.34e-05	0.000168	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARG—malignant glioma	5.25e-05	0.000165	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS1—malignant glioma	5.01e-05	0.000157	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—malignant glioma	4.98e-05	0.000156	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.78e-05	0.00015	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—BCHE—malignant glioma	4.65e-05	0.000146	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.6e-05	0.000144	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CB—malignant glioma	4.16e-05	0.000131	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—malignant glioma	4.13e-05	0.00013	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—malignant glioma	3.7e-05	0.000116	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CAT—malignant glioma	3.6e-05	0.000113	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—malignant glioma	3.6e-05	0.000113	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.51e-05	0.00011	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOR1—malignant glioma	3.4e-05	0.000107	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—malignant glioma	2.87e-05	9.02e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CAV1—malignant glioma	2.77e-05	8.72e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.54e-05	7.98e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.53e-05	7.94e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARG—malignant glioma	2.44e-05	7.66e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.22e-05	6.98e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—malignant glioma	2.07e-05	6.52e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.94e-05	6.08e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—malignant glioma	1.92e-05	6.03e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—malignant glioma	1.67e-05	5.26e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.18e-05	3.71e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—malignant glioma	9.64e-06	3.03e-05	CbGpPWpGaD
